Lars Alfredsson

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 394 publications

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

Shared etiology of late- and adult-onset multiple sclerosis.

Shared etiology of late- and adult-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 06, 2026

Dental amalgam exposure and multiple sclerosis: authors' response.

Dental amalgam exposure and multiple sclerosis: authors' response.

Journal: International journal of epidemiology

Published: July 18, 2026

Interaction between smoking and HLA-A*02:01 in multiple sclerosis progression.

Interaction between smoking and HLA-A*02:01 in multiple sclerosis progression.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 03, 2026

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 06, 2026

Occupational Exposure to Industrial Dust and Rates of Multiple Sclerosis.

Occupational Exposure to Industrial Dust and Rates of Multiple Sclerosis.

Journal: Neurology

Published: March 13, 2026

Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.

Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.

Journal: Clinical & translational immunology

Published: February 26, 2026

Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.

Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.

Journal: Journal of neurology

Published: February 17, 2026

Patterns and changes in lifestyle habits of patients with rheumatoid arthritis during the first three years post-diagnosis.

Patterns and changes in lifestyle habits of patients with rheumatoid arthritis during the first three years post-diagnosis.

Journal: Rheumatology (Oxford, England)

Published: January 30, 2026

Long-term disability after initiation of platform versus high-efficacy disease-modifying therapy in relapsing-onset multiple sclerosis.

Long-term disability after initiation of platform versus high-efficacy disease-modifying therapy in relapsing-onset multiple sclerosis.

Journal: Journal of neurology

Published: January 28, 2026

Concussion is associated with multiple sclerosis if it occurs before infectious mononucleosis.

Concussion is associated with multiple sclerosis if it occurs before infectious mononucleosis.

Journal: Brain communications

Published: January 24, 2026

Migration status, country of origin and long-term outcomes in multiple sclerosis: a Swedish nationwide study.

Migration status, country of origin and long-term outcomes in multiple sclerosis: a Swedish nationwide study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 16, 2026

Showing 1-12 of 394

Last Updated: 09/26/2026